
Overview
Christine L Hann, completed her MD and Ph.D. at Jefferson Medical College/Thomas Jefferson University follwed by an internal medicine residency at the University of Chicago Hospitals. Following a fellowship at Johns Hopkins University in Hematology and Oncology, Dr. Hann joined the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center as a member of the Upper Aerodigestive Cancer Program and sees patients with non-small cell and small cell lung cancer. Dr. Hann's research focus is on developing novel therapeutics for lung cancer, particularly small cell lung cancer (SCLC) and neuroendocrine tumors (NETs) such as carcinoid tumors of the lung. As a faculty member she is involved in both clinical and laboratory research. Specific research projects include: 1) Studying mechanisms of resistant to small molecule inhibitors of the antiapoptotic protein, BCL-2 using patient-derived xenograft models. Her preclinical work has led to an NCI-sponsored Phase 1/2 clinical trial combining a BCL-2 inhibitor with a TORC1/2 inhibitors which is currently underway (NCT03366103). 2) Preclinical evaluation of various therapeutics including epigenetic modulators (LSD1 inhibitors) and nanoliposome chemotherapy in SCLC PDXs; 3) Modeling and characterizing chemoradiotherapy resistance in preclinical models of SCLC. She, along with Dr. Luigi Marchionni in Biostatistics and Dr. Phuoc Tran in the Department of Radiation Oncology, were recently awarded a 5-year NCI-sponsored U01 grant to study mechanisms of chemoradiation resistance in SCLC. Dr. Hann is PI of several trials in SCLC and NSCLC and is leading investigator-initiated clinical trials in SCLC and NETs.
Dr. Hann is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Squamous Cell Lung Carcinoma.
Dr. Hann is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 93 peer reviewed articles and participating in 7 clinical trials. Dr. Hann is currently accepting new patients.
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Mason Lord Drive, Kimmel Cancer Center, Kimmel Cancer Center, Baltimore, MD 21224
201 North Broadway Street, Viragh BLDG 5th FL, Baltimore, MD 21287
10803 Falls Road, Pavilion III STE 1500, Lutherville, MD 21093
10803 Falls Rd, Ste 1500, Lutherville, MD 21093
Additional Areas of Focus
Dr. Hann has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist practicing medicine in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and Small Cell Lung Cancer (SCLC). Dr. Forde is currently accepting new patients.
Sidney Kimmel Comprehensive Cancer Center
Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy. Dr. Brodsky is board certified in American Board Of Internal Medicine. Dr. Brodsky is currently accepting new patients.
Office
Brigitte Widemann is a Hematologist and an Oncologist practicing medicine in Bethesda, Maryland. Dr. Widemann is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Neurofibromatosis, Malignant Peripheral Nerve Sheath Tumor, Fibrosarcoma, Medullary Thyroid Carcinoma, and Thyroidectomy.
Frequently Asked Questions about Dr. Christine Hann
How do I make an appointment with Dr. Christine Hann?
You can book an appointment with Dr. Christine Hann by calling their office at 410-550-1711. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Christine Hann a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Christine Hann is classified as an Elite expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Christine Hann specialize in?
While Dr. Christine Hann is a Hematology, they have specific expertise in Small Cell Lung Cancer (SCLC), Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Christine Hann participate in research or clinical trials?
Yes. Dr. Christine Hann has published 93 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Christine Hann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Christine Hann accept my insurance?
Dr. Christine Hann accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-550-1711 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Hann isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Hann isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Hann isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Hann isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Hann isDistinguished. Learn about Lung Adenocarcinoma.
- Neuroendocrine TumorDr. Hann isDistinguished. Learn about Neuroendocrine Tumor.
- Pleuropulmonary BlastomaDr. Hann isDistinguished. Learn about Pleuropulmonary Blastoma.
- Squamous Cell Lung CarcinomaDr. Hann isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Thymic Epithelial TumorDr. Hann isDistinguished. Learn about Thymic Epithelial Tumor.
- Advanced
- ChordomaDr. Hann isAdvanced. Learn about Chordoma.
- Familial Pancreatic CancerDr. Hann isAdvanced. Learn about Familial Pancreatic Cancer.
- Pancreatic CancerDr. Hann isAdvanced. Learn about Pancreatic Cancer.
- Experienced
- AstrocytomaDr. Hann isExperienced. Learn about Astrocytoma.
- Brain TumorDr. Hann isExperienced. Learn about Brain Tumor.
- Embryonal Tumor with Multilayered Rosettes
- Familial Prostate CancerDr. Hann isExperienced. Learn about Familial Prostate Cancer.
- Febrile NeutropeniaDr. Hann isExperienced. Learn about Febrile Neutropenia.
- Gastroesophageal Junction CancerDr. Hann isExperienced. Learn about Gastroesophageal Junction Cancer.
- GlioblastomaDr. Hann isExperienced. Learn about Glioblastoma.
- GliomaDr. Hann isExperienced. Learn about Glioma.
- Gliomatosis CerebriDr. Hann isExperienced. Learn about Gliomatosis Cerebri.
- MelanomaDr. Hann isExperienced. Learn about Melanoma.
- MesotheliomaDr. Hann isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Hann isExperienced. Learn about Metastatic Brain Tumor.
- Metastatic Uveal MelanomaDr. Hann isExperienced. Learn about Metastatic Uveal Melanoma.
- NeuroblastomaDr. Hann isExperienced. Learn about Neuroblastoma.
- Olfactory NeuroblastomaDr. Hann isExperienced. Learn about Olfactory Neuroblastoma.
- Posterior Fossa TumorDr. Hann isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- ThrombocytopeniaDr. Hann isExperienced. Learn about Thrombocytopenia.
